Cargando…
Methylphenidate for Mild Cognitive Impairment: An Exploratory 3-Day, Randomized, Double-Blind, Placebo-Controlled Trial
Background: To evaluate the efficacy, safety and tolerability of methylphenidate (MPH) for cognitive function in older patients with mild cognitive impairment (MCI). Methods: Male and female subjects aged 65 years and older with a clinical diagnosis MCI were included in an exploratory randomized, do...
Autores principales: | Press, Yan, Punchik, Boris, Kagan, Ella, Berzak, Alexander, Freud, Tamar, Dwolatzky, Tzvi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900434/ https://www.ncbi.nlm.nih.gov/pubmed/33634145 http://dx.doi.org/10.3389/fmed.2021.594228 |
Ejemplares similares
-
Validation of the Russian Version of the MoCA Test as a Cognitive Screening Instrument in Cognitively Asymptomatic Older Individuals and Those With Mild Cognitive Impairment
por: Freud, Tamar, et al.
Publicado: (2020) -
Visual-spatial perception: a comparison between instruments frequently used in the primary care setting and a computerized cognitive assessment battery
por: Punchik, Boris, et al.
Publicado: (2015) -
Which factors affect the implementation of geriatric recommendations by primary care physicians?
por: Press, Yan, et al.
Publicado: (2017) -
Orthostatic Hypotension and Mortality in Elderly Frail Patients: A Retrospective Cross-Sectional Study
por: Freud, Tamar, et al.
Publicado: (2015) -
Can home care for homebound patients with chronic heart failure reduce hospitalizations and costs?
por: Punchik, Boris, et al.
Publicado: (2017)